Costs and quality of life in multiple sclerosis: a cross-sectional observational study in Germany

G Kobelt, P Lindgren, A Smala, B Jönsson - 2000 - econstor.eu
We performed a cross-sectional, bottom-up observational study of resource consumption
and quality of life of patients with multiple sclerosis (MS) in Germany. Six centers …

Perspectives in multiple sclerosis health care: Special focus on the costs of multiple sclerosis

Z Rotstein, R Hazan, Y Barak, A Achiron - Autoimmunity Reviews, 2006 - Elsevier
Brain disorders are amongst the leading causes of disease and disability worldwide,
accounting for 35% of the burden of all diseases in Europe. Despite their enormous …

[HTML][HTML] Multiple sclerosis registry in Germany: results of the extension phase 2005/2006

P Flachenecker, K Stuke, W Elias… - Deutsches Ärzteblatt …, 2008 - ncbi.nlm.nih.gov
Methods After a 2-year pilot phase, the original entry mask was modified, and new centers
were recruited, resulting in the registration of a total of 5821 patients in 2005 and 2006 …

Effectiveness of multiple sclerosis treatment with current immunomodulatory drugs

R Milo - Expert opinion on pharmacotherapy, 2015 - Taylor & Francis
Introduction: Multiple sclerosis (MS) is a chronic inflammatory disease of the CNS of a
putative autoimmune origin characterized by neurologic dysfunction disseminated in space …

Healthcare, sickness absence, and disability pension cost trajectories in the first 5 years after diagnosis with multiple sclerosis: a prospective register-based cohort …

K Karampampa, H Gyllensten, F Yang, C Murley… - PharmacoEconomics …, 2020 - Springer
Objectives The aim was to longitudinally explore the healthcare, sickness absence (SA), and
disability pension (DP) cost trajectories among newly diagnosed people with multiple …

The payer's perspective: what is the burden of MS and how should the patient's perspective be integrated in health technology assessment conducted for taking …

R Gold, M Toumi, B Meesen… - Multiple Sclerosis …, 2016 - journals.sagepub.com
Background: In Europe, there exists considerable variability in access to care and treatment
for multiple sclerosis (MS). Objectives: To improve this situation, we identified key issues …

Physician and patient treatment decision-making in relapsing-remitting multiple sclerosis in Europe and the USA

H Brown, S Gabriele, J White - Neurodegenerative disease …, 2018 - Taylor & Francis
Objective: To assess factors used in treatment decision-making for relapsing-remitting
multiple sclerosis in both the 5EU (UK/Germany/France/Italy/Spain) and the USA. Methods …

Health-related outcomes, health care resource utilization, and costs of multiple sclerosis in Japan compared with US and five EU countries

K Yamabe, MD DiBonaventura… - … and Outcomes Research, 2019 - Taylor & Francis
Purpose Multiple sclerosis (MS) imposes a huge burden on patients. This study examined
the relationship between MS and health-related and economic burden in Japan; …

Cost-of-illness progression before and after diagnosis of multiple sclerosis: a nationwide register-based cohort study in sweden of people newly diagnosed with …

C Murley, P Tinghög, K Alexanderson, J Hillert… - …, 2021 - Springer
Background Multiple sclerosis (MS) is a chronic disease associated with increased
healthcare utilisation and productivity losses. Objective The objective of this study was to …

A population‐based study comparing multiple sclerosis clinic users and non‐users in British Columbia, Canada

KA McKay, H Tremlett, F Zhu… - European Journal of …, 2016 - Wiley Online Library
Background and purpose Much clinical knowledge about multiple sclerosis (MS) has been
gained from patients who attend MS specialty clinics. However, there is limited information …